GlassScriptPhysician profile
Timothy Hf Daugherty
NPI 1780066738
$20,507.63
in general payments reported to CMS, 2019-2025
10 companies · $20K in 2025
The $20K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $184 · 2022: $366 · 2023: $174 · 2024: $49.76 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $2,130 · Travel and Lodging: $1,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,875.00 |
| Food and Beverage | $2,130.20 |
| Travel and Lodging | $1,751.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $19,422.00 | 2023-2025 | Avance Nerve Graft |
| Checkpoint Surgical, INC | $281.52 | 2019-2025 | Checkpoint Stimulators |
| Endo Pharmaceuticals INC. | $271.81 | 2019-2022 | |
| Depuy Synthes Sales INC. | $166.51 | 2020-2023 | Lcp |
| Integra Lifesciences Corporation | $120.60 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Trimed, INC. | $112.43 | 2019 | |
| Trice Medical, INC. | $50.00 | 2020 | |
| Stryker Corporation | $49.76 | 2024 | Variax |
| Allergan, INC. | $18.01 | 2020 | |
| Baudax Bio INC. | $14.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Daugherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.